Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery.


Journal

Journal of reproductive immunology
ISSN: 1872-7603
Titre abrégé: J Reprod Immunol
Pays: Ireland
ID NLM: 8001906

Informations de publication

Date de publication:
04 2021
Historique:
received: 08 01 2021
accepted: 28 01 2021
pubmed: 15 2 2021
medline: 9 3 2021
entrez: 14 2 2021
Statut: ppublish

Résumé

We report herein the longest-lasting study of SARS-CoV-2 antibody profile in pregnancy, from first trimester-infection to delivery. Seventeen out of 164 pregnant women tested positive for COVID-19. Throughout pregnancy, the neutralizing antibody titer remained stable, whilst a significant decline in the non-neutralizing antibodies was observed after 16 weeks of gestation. All the newborns of women who developed IgG antibodies showed the presence of the same antibodies in arterial cord blood. Knowledge on the longevity and type of SARS-CoV-2 antibody response may help to guide vaccination strategies in pregnancy.

Identifiants

pubmed: 33582489
pii: S0165-0378(21)00015-2
doi: 10.1016/j.jri.2021.103285
pmc: PMC7973007
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
Immunoglobulin G 0

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103285

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:375-376
pubmed: 31088698
JAMA Netw Open. 2020 Dec 1;3(12):e2030455
pubmed: 33351086
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
Nat Microbiol. 2020 Dec;5(12):1598-1607
pubmed: 33106674
Am J Obstet Gynecol. 2021 Apr;224(4):391.e1-391.e7
pubmed: 33039396
J Med Virol. 2021 Jan;93(1):537-540
pubmed: 32633869
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Emerg Infect Dis. 2021 Mar;27(3):928-931
pubmed: 33350923
Eur J Obstet Gynecol Reprod Biol. 2020 Jul;250:246-249
pubmed: 32418711

Auteurs

Stefano Cosma (S)

Gynecology and Obstetrics 1, Department of Surgical Sciences, City of Health and Science, University of Turin, Turin, Italy.

Andrea Roberto Carosso (AR)

Gynecology and Obstetrics 1, Department of Surgical Sciences, City of Health and Science, University of Turin, Turin, Italy. Electronic address: andrea88.carosso@gmail.com.

Silvia Corcione (S)

Infectious Diseases, Department of Medical Sciences, University of Turin, Turin, Italy; Tufts University School of Medicine, Boston, MA, USA.

Jessica Cusato (J)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Amedeo di Savoia Hospital, Department of Medical Sciences, University of Turin, Turin, Italy.

Fulvio Borella (F)

Gynecology and Obstetrics 1, Department of Surgical Sciences, City of Health and Science, University of Turin, Turin, Italy.

Miriam Antonucci (M)

Laboratory of Clinical Pharmacology and Pharmacogenetics, Amedeo di Savoia Hospital, Department of Medical Sciences, University of Turin, Turin, Italy.

Luca Marozio (L)

Gynecology and Obstetrics 1, Department of Surgical Sciences, City of Health and Science, University of Turin, Turin, Italy.

Alberto Revelli (A)

Gynecology and Obstetrics 1, Department of Surgical Sciences, City of Health and Science, University of Turin, Turin, Italy.

Mario Preti (M)

Gynecology and Obstetrics 1, Department of Surgical Sciences, City of Health and Science, University of Turin, Turin, Italy.

Valeria Ghisetti (V)

Laboratory of Microbiology and Virology, Amedeo di Savoia Hospital, ASL 'Città di Torino', Turin, Italy.

Giovanni Di Perri (G)

Unit of Infectious Diseases, Amedeo di Savoia Hospital, Department of Medical Sciences, University of Turin, Turin, Italy.

Chiara Benedetto (C)

Gynecology and Obstetrics 1, Department of Surgical Sciences, City of Health and Science, University of Turin, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH